Minimally invasive gynecology
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
200
NCT03725306
Librata Endometrial Ablation Device Treatment to Reduce Menstrual Blood Loss
Phase: Phase 3
Role: Lead Sponsor
Start: Jan 1, 2019
Completion: Dec 1, 2022
Loading map...